Clinical Trials in Texas

Showing 2321-2340 of 7,265 trials

Changes in Amino Acid Absorption After Adding a Probiotic to an Acute Protein Feeding

NCT06701604

The purpose of this study is to examine the rate and concentration of amino acid absorption after a three-week pattern of milk protein supplementation with and without the addition of a single strain probiotic.

Amino Acid AbsorptionProbiotic

The Archer-Daniels-Midland Company30 participantsStarted Dec 2024

Belton, Texas, United States

COMPLETEDPhase 237 miles

A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)

NCT03192176

This study determined the effects of different doses and dosing regimens of ESN364 on the frequency and severity of hot flashes. The treatment was administered for 12 weeks to postmenopausal women, aged 40 to 65, suffering at least 50 moderate to severe hot flashes per week.

MenopauseHot Flashes

Astellas Pharma Global Development, Inc.356 participantsStarted Jul 2017

Anniston, Alabama, United States • Birmingham, Alabama, United States • Phoenix, Arizona, United States +48 more locations

Changes in Amino Acid Absorption After Adding a Probiotic to an Acute Protein Feeding

A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)

Find Trials by Condition in Texas

Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System.

Safety and Immunogenicity of RNA-based Vaccines Against SARS-CoV-2 Variants in Healthy Participants

Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects With Overactive Bladder (OAB)

A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer

Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144

FPA150 in Patients With Advanced Solid Tumors

A Study of Lebrikizumab (LY3650150) Administered by Two Different Devices in Healthy Participants

Study of Pemetrexed + Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With Tyrosine Kinase Inhibitor- (TKI)-Resistant Epidermal Growth Factor Receptor- (EGFR)-Mutated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-789/KEYNOTE-789)

A Study to Determine the Recommended Dose and Regimen and to Evaluate the Safety and Preliminary Efficacy of CC-92480 in Combination With Standard Treatments in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) and Newly Diagnosed Multiple Myeloma (NDMM)

A Study of ZN-c3 in Patients With Ovarian Cancer

MIRACLE of LIFE Study

Long-Term Extension Trial of Tildrakizumab to Prove Its Safety in Subjects With Psoriatic Arthritis Who Have Previously Completed Study With Tildrakizumab.

Analysis of Both Sex and Device Specific Factors on Outcomes in Patients with Non-Ischemic Cardiomyopathy

ProACT Post-Approval Study

Trial to Evaluate Efficacy and Safety of Apraglutide in SBS-IF

ME-344 and Bevacizumab in Previously Treated Metastatic Colorectal Cancer

HIFEM and Radiofrequency for Muscular System Function Improvement

A Study Investigating the Safety, Tolerability and Efficacy of ASP7517 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (AML) and Relapsed/Refractory Higher Risk Myelodysplastic Syndrome (MDS)